Raynaud's phenomenon and chronic/recurrent digital ulcers (DU) are main features of systemic sclerosis (SSc). Their treatment includes both systemic (i.e., iloprost) and local therapies. We report the therapeutic effects of iloprost in a cohort of SSc patients during a long-lasting follow-up period.
Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study / Colaci, Michele; Lumetti, Federica; Giuggioli, Dilia; Guiducci, Serena; Bellando-Randone, Silvia; Fiori, Ginevra; Matucci-Cerinic, Marco; Ferri, Clodoveo. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 35 Suppl 106:(2017), pp. 179-183.
Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study
Matucci-Cerinic, Marco;
2017-01-01
Abstract
Raynaud's phenomenon and chronic/recurrent digital ulcers (DU) are main features of systemic sclerosis (SSc). Their treatment includes both systemic (i.e., iloprost) and local therapies. We report the therapeutic effects of iloprost in a cohort of SSc patients during a long-lasting follow-up period.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
